283 related articles for article (PubMed ID: 15588409)
1. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor.
Steffens GC; Yao C; Prével P; Markowicz M; Schenck P; Noah EM; Pallua N
Tissue Eng; 2004; 10(9-10):1502-9. PubMed ID: 15588409
[TBL] [Abstract][Full Text] [Related]
2. Tissue substitutes with improved angiogenic capabilities: an in vitro investigation with endothelial cells and endothelial progenitor cells.
Grieb G; Groger A; Piatkowski A; Markowicz M; Steffens GC; Pallua N
Cells Tissues Organs; 2010; 191(2):96-104. PubMed ID: 19641290
[TBL] [Abstract][Full Text] [Related]
3. The effect of cross-linking of collagen matrices on their angiogenic capability.
Yao C; Markowicz M; Pallua N; Noah EM; Steffens G
Biomaterials; 2008 Jan; 29(1):66-74. PubMed ID: 17935778
[TBL] [Abstract][Full Text] [Related]
4. Effects of modified collagen matrices on human umbilical vein endothelial cells.
Markowicz M; Heitland A; Steffens GC; Pallua N
Int J Artif Organs; 2005 Dec; 28(12):1251-8. PubMed ID: 16404702
[TBL] [Abstract][Full Text] [Related]
5. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF.
Koch S; Yao Ch; Grieb G; Prével P; Noah EM; Steffens GC
J Mater Sci Mater Med; 2006 Aug; 17(8):735-41. PubMed ID: 16897166
[TBL] [Abstract][Full Text] [Related]
6. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices.
Yao C; Roderfeld M; Rath T; Roeb E; Bernhagen J; Steffens G
Biomaterials; 2006 Mar; 27(8):1608-16. PubMed ID: 16183114
[TBL] [Abstract][Full Text] [Related]
7. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.
d'Angelo I; Oliviero O; Ungaro F; Quaglia F; Netti PA
Acta Biomater; 2013 Jul; 9(7):7389-98. PubMed ID: 23523534
[TBL] [Abstract][Full Text] [Related]
8. Modification of collagen matrices for enhancing angiogenesis.
Yao C; Prével P; Koch S; Schenck P; Noah EM; Pallua N; Steffens G
Cells Tissues Organs; 2004; 178(4):189-96. PubMed ID: 15812146
[TBL] [Abstract][Full Text] [Related]
9. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.
Zieris A; Chwalek K; Prokoph S; Levental KR; Welzel PB; Freudenberg U; Werner C
J Control Release; 2011 Nov; 156(1):28-36. PubMed ID: 21763368
[TBL] [Abstract][Full Text] [Related]
10. Influence of modified extracellular matrices on TI6AL4V implants on binding and release of VEGF.
Wolf-Brandstetter C; Lode A; Hanke T; Scharnweber D; Worch H
J Biomed Mater Res A; 2006 Dec; 79(4):882-94. PubMed ID: 16941591
[TBL] [Abstract][Full Text] [Related]
11. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
Biomaterials; 2007 Feb; 28(6):1123-31. PubMed ID: 17113636
[TBL] [Abstract][Full Text] [Related]
12. The effect of heparinized decellularized scaffolds on angiogenic capability.
Wu Q; Li Y; Wang Y; Li L; Jiang X; Tang J; Yang H; Zhang J; Bao J; Bu H
J Biomed Mater Res A; 2016 Dec; 104(12):3021-3030. PubMed ID: 27459086
[TBL] [Abstract][Full Text] [Related]
13. Modulation of angiogenic potential of tissue-engineered peripheral nerve by covalent incorporation of heparin and loading with vascular endothelial growth factor.
Zhao B; Zhao Z; Ma J; Ma X
Neurosci Lett; 2019 Jul; 705():259-264. PubMed ID: 30639395
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-derived matrix (FDM) as a novel vascular endothelial growth factor delivery platform.
Du P; Hwang MP; Noh YK; Subbiah R; Kim IG; Bae SE; Park K
J Control Release; 2014 Nov; 194():122-9. PubMed ID: 25194780
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres.
Borselli C; Ungaro F; Oliviero O; d'Angelo I; Quaglia F; La Rotonda MI; Netti PA
J Biomed Mater Res A; 2010 Jan; 92(1):94-102. PubMed ID: 19165799
[TBL] [Abstract][Full Text] [Related]
17. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
J Control Release; 2006 Nov; 116(2):e88-90. PubMed ID: 17718989
[No Abstract] [Full Text] [Related]
18. Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold.
Chen L; He Z; Chen B; Yang M; Zhao Y; Sun W; Xiao Z; Zhang J; Dai J
J Mater Sci Mater Med; 2010 Jan; 21(1):309-17. PubMed ID: 19634004
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
Tan Q; Tang H; Hu J; Hu Y; Zhou X; Tao Y; Wu Z
Int J Nanomedicine; 2011; 6():929-42. PubMed ID: 21720505
[TBL] [Abstract][Full Text] [Related]
20. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering.
Chiu LL; Weisel RD; Li RK; Radisic M
J Tissue Eng Regen Med; 2011 Jan; 5(1):69-84. PubMed ID: 20717888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
